• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[患有注意力缺陷多动障碍(ADHD)和物质使用障碍的青少年;国际共识]

[Adolescents with concurrent ADHD and substance use disorder; international consensus].

作者信息

Spijkerman R, Crunelle C L, Özgen M H, Begeman A H A, Dom G, van de Glind G, Groenman A P, van Kernebeek M W, Matthys F, Post M, Schellekens A, Staal W, van den Brink W, Hendriks V M

出版信息

Tijdschr Psychiatr. 2021;63(12):868-874.

PMID:34978058
Abstract

BACKGROUND

Substance use disorder (SUD) is common among youths with attention-deficit/hyperactivity disorder (ADHD). Co-morbid ADHD and SUD in youths complicates screening, diagnosis, and treatment of both disorders and is associated with worse treatment prognosis. Limited research in youths with SUD and co-morbid ADHD provides insufficient basis for firm recommendations. To offer clinicians some guidance on this topic, we present the results of an international consensus procedure.

AIM

To summarize an international consensus on diagnosis and treatment of young people with comorbid ADHD and SUD.

METHOD

In a modified Delphi-study, a multidisciplinary, international group of 55 experts strived to reach consensus on 37 recommendations.

RESULTS

Consensus was reached on 36 recommendations. Routine screening of ADHD and/or SUD is important. For the treatment of co-morbid SUD and ADHD in youths, both psychosocial and pharmacological treatment should be considered. Psychosocial treatment should preferably consist of psychoeducation, motivational interviewing (MI), and cognitive behavioral therapy (CBT) focused on SUD or both disorders. Long-acting stimulants are recommended as first choice pharmacotherapy, preferably embedded in psychosocial treatment. Experts did not agree on the precondition that patients need to be abstinent before starting stimulant treatment.

CONCLUSION

Clinicians and youths with co-morbid SUD and ADHD can use this international consensus to choose the best possible treatment.

摘要

背景

物质使用障碍(SUD)在患有注意力缺陷多动障碍(ADHD)的青少年中很常见。青少年中ADHD与SUD共病会使这两种疾病的筛查、诊断和治疗变得复杂,并且与更差的治疗预后相关。对患有SUD和共病ADHD的青少年的研究有限,无法为明确的建议提供充分依据。为了给临床医生提供关于这个主题的一些指导,我们展示了一项国际共识程序的结果。

目的

总结关于共病ADHD和SUD的青少年诊断和治疗的国际共识。

方法

在一项改良的德尔菲研究中,一个由55名专家组成的多学科国际小组努力就37项建议达成共识。

结果

就36项建议达成了共识。对ADHD和/或SUD进行常规筛查很重要。对于青少年共病SUD和ADHD的治疗,应同时考虑心理社会治疗和药物治疗。心理社会治疗最好包括心理教育、动机性访谈(MI)以及针对SUD或两种疾病的认知行为疗法(CBT)。推荐长效兴奋剂作为首选药物治疗,最好将其纳入心理社会治疗中。专家们对于患者在开始兴奋剂治疗前需要戒除物质这一前提条件未达成一致意见。

结论

患有共病SUD和ADHD的临床医生和青少年可以利用这一国际共识来选择最佳治疗方案。

相似文献

1
[Adolescents with concurrent ADHD and substance use disorder; international consensus].[患有注意力缺陷多动障碍(ADHD)和物质使用障碍的青少年;国际共识]
Tijdschr Psychiatr. 2021;63(12):868-874.
2
[International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder].[关于同时患有注意力缺陷多动障碍和物质使用障碍的青少年筛查、诊断和治疗的国际共识声明]
Z Kinder Jugendpsychiatr Psychother. 2021 Jan;50(1):54-67. doi: 10.1024/1422-4917/a000828. Epub 2021 Aug 16.
3
International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.国际共识声明:青少年注意力缺陷/多动障碍与物质使用障碍共病的筛查、诊断与治疗。
Eur Addict Res. 2020;26(4-5):223-232. doi: 10.1159/000508385. Epub 2020 Jul 7.
4
[International consensus for the screening, diagnosis and treatment of adult patients with substance use disorder and ADHD].[成人物质使用障碍和注意力缺陷多动障碍患者筛查、诊断及治疗的国际共识]
Tijdschr Psychiatr. 2019;61(7):477-487.
5
International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.国际物质使用障碍共病注意缺陷/多动障碍患者筛查、诊断和治疗共识声明。
Eur Addict Res. 2018;24(1):43-51. doi: 10.1159/000487767. Epub 2018 Mar 6.
6
A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.对多动症合并物质使用障碍患者使用精神刺激药物所产生问题的定性综述。
Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908x280707. Epub 2008 Apr 1.
7
Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications.注意缺陷多动障碍患者的物质滥用:治疗意义
CNS Drugs. 2005;19(8):643-55. doi: 10.2165/00023210-200519080-00001.
8
[Recommendations for the screening, diagnosis and treatment of patients with comorbid attention deficit hyperactivity- and substance use disorder].[注意缺陷多动障碍与物质使用障碍共病患者的筛查、诊断和治疗建议]
Psychiatr Hung. 2020;35(4):435-447.
9
Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.在存在物质使用障碍的情况下管理注意力缺陷/多动障碍。
J Clin Psychiatry. 2007;68 Suppl 11:23-30.
10
Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.青少年物质使用多动障碍(ADHD)多模式治疗研究(MTA)作为儿童 ADHD、随机分配到儿童治疗和随后药物治疗的功能。
J Am Acad Child Adolesc Psychiatry. 2013 Mar;52(3):250-63. doi: 10.1016/j.jaac.2012.12.014. Epub 2013 Feb 8.